240 related articles for article (PubMed ID: 18227067)
21. Surface expression and channel function of TRPM8 are cooperatively controlled by transmembrane segments S3 and S4.
Kühn FJ; Winking M; Kühn C; Hoffmann DC; Lückhoff A
Pflugers Arch; 2013 Nov; 465(11):1599-610. PubMed ID: 23708837
[TBL] [Abstract][Full Text] [Related]
22. Functional roles of charged residues in the putative voltage sensor of the HCN2 pacemaker channel.
Chen J; Mitcheson JS; Lin M; Sanguinetti MC
J Biol Chem; 2000 Nov; 275(46):36465-71. PubMed ID: 10962006
[TBL] [Abstract][Full Text] [Related]
23. The influence of DOCA-salt hypertension and chronic administration of the FAAH inhibitor URB597 on K
Kloza M; Baranowska-Kuczko M; Malinowska B; Karpińska O; Harasim-Symbor E; Kasacka I; Kozłowska H
Vascul Pharmacol; 2017 Dec; 99():65-73. PubMed ID: 29038048
[TBL] [Abstract][Full Text] [Related]
24. Role of hydrophobic and ionic forces in the movement of S4 of the Shaker potassium channel.
Elliott DJ; Neale EJ; Munsey TS; Bannister JP; Sivaprasadarao A
Mol Membr Biol; 2012 Dec; 29(8):321-32. PubMed ID: 22881396
[TBL] [Abstract][Full Text] [Related]
25. ATP-dependent activation of the intermediate conductance, Ca2+-activated K+ channel, hIK1, is conferred by a C-terminal domain.
Gerlach AC; Syme CA; Giltinan L; Adelman JP; Devors DC
J Biol Chem; 2001 Jun; 276(24):10963-70. PubMed ID: 11439928
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of KCa3.1 by depolarisation and 2-aminoethoxydiphenyl borate (2-APB) during Ca²⁺ release activated Ca²⁺ (CRAC) entry in human erythroleukemia (HEL) cells: Implications for the interpretation of 2-APB inhibition of CRAC entry.
Littlechild R; Zaidman N; Khodaverdi D; Mason MJ
Cell Calcium; 2015 Feb; 57(2):76-88. PubMed ID: 25601026
[TBL] [Abstract][Full Text] [Related]
27. Hydrophobic interactions as key determinants to the KCa3.1 channel closed configuration. An analysis of KCa3.1 mutants constitutively active in zero Ca2+.
Garneau L; Klein H; Banderali U; Longprá-Lauzon A; Parent L; Sauvá R
J Biol Chem; 2009 Jan; 284(1):389-403. PubMed ID: 18996847
[TBL] [Abstract][Full Text] [Related]
28. Molecular dissection of the contribution of negatively and positively charged residues in S2, S3, and S4 to the final membrane topology of the voltage sensor in the K+ channel, KAT1.
Sato Y; Sakaguchi M; Goshima S; Nakamura T; Uozumi N
J Biol Chem; 2003 Apr; 278(15):13227-34. PubMed ID: 12556517
[TBL] [Abstract][Full Text] [Related]
29. Role of arginine residues on the S4 segment of the Bacillus halodurans Na+ channel in voltage-sensing.
Chahine M; Pilote S; Pouliot V; Takami H; Sato C
J Membr Biol; 2004 Sep; 201(1):9-24. PubMed ID: 15635808
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological activation of KCa3.1/KCa2.3 channels produces endothelial hyperpolarization and lowers blood pressure in conscious dogs.
Damkjaer M; Nielsen G; Bodendiek S; Staehr M; Gramsbergen JB; de Wit C; Jensen BL; Simonsen U; Bie P; Wulff H; Köhler R
Br J Pharmacol; 2012 Jan; 165(1):223-34. PubMed ID: 21699504
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of the KCa3.1 channels by AMP-activated protein kinase in human airway epithelial cells.
Klein H; Garneau L; Trinh NT; Privé A; Dionne F; Goupil E; Thuringer D; Parent L; Brochiero E; Sauvé R
Am J Physiol Cell Physiol; 2009 Feb; 296(2):C285-95. PubMed ID: 19052260
[TBL] [Abstract][Full Text] [Related]
32. Recycling of the Ca2+-activated K+ channel, KCa2.3, is dependent upon RME-1, Rab35/EPI64C, and an N-terminal domain.
Gao Y; Balut CM; Bailey MA; Patino-Lopez G; Shaw S; Devor DC
J Biol Chem; 2010 Jun; 285(23):17938-53. PubMed ID: 20360009
[TBL] [Abstract][Full Text] [Related]
33. Role of the S4 in cooperativity of voltage-dependent potassium channel activation.
Smith-Maxwell CJ; Ledwell JL; Aldrich RW
J Gen Physiol; 1998 Mar; 111(3):399-420. PubMed ID: 9482708
[TBL] [Abstract][Full Text] [Related]
34. A novel pan-negative-gating modulator of KCa2/3 channels, fluoro-di-benzoate, RA-2, inhibits endothelium-derived hyperpolarization-type relaxation in coronary artery and produces bradycardia in vivo.
Oliván-Viguera A; Valero MS; Coleman N; Brown BM; Laría C; Murillo MD; Gálvez JA; Díaz-de-Villegas MD; Wulff H; Badorrey R; Köhler R
Mol Pharmacol; 2015 Feb; 87(2):338-48. PubMed ID: 25468883
[TBL] [Abstract][Full Text] [Related]
35. LQT1-associated mutations increase KCNQ1 proteasomal degradation independently of Derlin-1.
Peroz D; Dahimène S; Baró I; Loussouarn G; Mérot J
J Biol Chem; 2009 Feb; 284(8):5250-6. PubMed ID: 19114714
[TBL] [Abstract][Full Text] [Related]
36. Role of Domain IV/S4 outermost arginines in gating of T-type calcium channels.
Lam AD; Chikina MD; McNulty MM; Glaaser IW; Hanck DA
Pflugers Arch; 2005 Nov; 451(2):349-61. PubMed ID: 16133267
[TBL] [Abstract][Full Text] [Related]
37. Trafficking of intermediate (KCa3.1) and small (KCa2.x) conductance, Ca(2+)-activated K(+) channels: a novel target for medicinal chemistry efforts?
Balut CM; Hamilton KL; Devor DC
ChemMedChem; 2012 Oct; 7(10):1741-55. PubMed ID: 22887933
[TBL] [Abstract][Full Text] [Related]
38. Toward the rational design of constitutively active KCa3.1 mutant channels.
Garneau L; Klein H; Parent L; Sauvé R
Methods Enzymol; 2010; 485():437-57. PubMed ID: 21050931
[TBL] [Abstract][Full Text] [Related]
39. Identification of a surface charged residue in the S3-S4 linker of the pacemaker (HCN) channel that influences activation gating.
Henrikson CA; Xue T; Dong P; Sang D; Marban E; Li RA
J Biol Chem; 2003 Apr; 278(16):13647-54. PubMed ID: 12582169
[TBL] [Abstract][Full Text] [Related]
40. Investigating CFTR and KCa3.1 Protein/Protein Interactions.
Klein H; Abu-Arish A; Trinh NT; Luo Y; Wiseman PW; Hanrahan JW; Brochiero E; Sauvé R
PLoS One; 2016; 11(4):e0153665. PubMed ID: 27092946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
